• About us
• Contact

Advertisement

Document › Details

Acacia Pharma Group Ltd.. (2/5/18). "Press Release: Acacia Pharma Announces Its Intention to Launch an Initial Global Offering and to List Its Shares on Euronext Brussels [Not for US, AU, CA, JP, ZA, et al.]". Cambridge & Indianapolis, IN.

	Organisation	Acacia Pharma Ltd.
	Group	Acacia Pharma (Group)
	Organisation 2	Euronext Brussels
	Group	Euronext (Group)
	Product	Baremsis (APD421)
	Product 2	investment banking
	Index term	Acacia Pharma–SEVERAL: investment, 201802–201803 initial global offering €40m private placement 11.1m shares at €3.6 + listing on Euronext Brussels

Record changed: 2023-06-05

Advertisement

More documents for Acacia Pharma (Group)

• [1] Paion AG. (7/2/20). "Press Release: Paion Announces U.S. FDA Approval of Remimazolam (Byfavo) for the Induction and Maintenance of Procedural Sedation". Aachen....
• [2] Euronext N.V.. (3/5/18). "Press Release: Acacia Pharma Lists on Euronext Brussels". Brussels....
• [3] Acacia Pharma Group Ltd.. (3/2/18). "Press Release: Acacia Pharma Successfully Prices Initial Global Offering at EUR 3.60 per Share Raising EUR40m [Not for US, AU, CA, JP, ZA, et al.]". Cambridge & Indianapolis, IN....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2023. Made in Germany.